4//SEC Filing
Kanner Steven 4
Accession 0001209191-22-047748
CIK 0001619856other
Filed
Aug 25, 8:00 PM ET
Accepted
Aug 26, 5:42 PM ET
Size
9.5 KB
Accession
0001209191-22-047748
Insider Transaction Report
Form 4
Kanner Steven
Chief Scientific Officer
Transactions
- Exercise/Conversion
Common Stock
2022-08-25$2.69/sh+43,248$116,337→ 345,307 total - Exercise/Conversion
Option to purchase Common Stock
2022-08-25−43,248→ 73,601 totalExercise: $2.69Exp: 2029-09-30→ Common Stock (43,248 underlying) - Sale
Common Stock
2022-08-25$11.22/sh−43,248$485,221→ 302,059 total
Footnotes (3)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 24, 2022.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.88 to $11.37, inclusive. The reporting person undertakes to provide to Caribou Biosciences, Inc., any security holder of Caribou Biosciences, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2) to this Form 4.
- [F3]1/4th of the shares subject to this option vested on October 1, 2020 and an additional 1/48th of the aggregate number of shares subject to the option have vested or will vest on the corresponding day of each month thereafter, subject to the reporting person's continued services to the Issuer through the applicable vesting dates.
Documents
Issuer
Caribou Biosciences, Inc.
CIK 0001619856
Entity typeother
Related Parties
1- filerCIK 0001871131
Filing Metadata
- Form type
- 4
- Filed
- Aug 25, 8:00 PM ET
- Accepted
- Aug 26, 5:42 PM ET
- Size
- 9.5 KB